Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models.

MLA

Troiani, Teresa, et al. “Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 21, no. 18, Sept. 2015, pp. 4153–64. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-15-0211.

APA

Troiani, T., Napolitano, S., Martini, G., Martinelli, E., Cardone, C., Normanno, N., Vitagliano, D., Morgillo, F., Fenizia, F., Lambiase, M., Formisano, L., Bianco, R., Ciardiello, D., & Ciardiello, F. (2015). Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(18), 4153–4164. https://doi.org/10.1158/1078-0432.CCR-15-0211

Chicago

Troiani, Teresa, Stefania Napolitano, Giulia Martini, Erika Martinelli, Claudia Cardone, Nicola Normanno, Donata Vitagliano, et al. 2015. “Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 21 (18): 4153–64. doi:10.1158/1078-0432.CCR-15-0211.